Butafosfan 100 mg

Cyanocobalamin 0.05 mg

Cattle

Supportive treatment and prevention of hypophosphatemia and/or cyanocobalamin (vitamin B12) deficiency.

Supportive treatment to restore rumination following surgical treatment of displaced abomasum associated with secondary ketosis. 
Complementary treatment of parturient paresis in addition to Ca/Mg therapy. 
Prevention of ketosis development, if administered before calving. 

Intravenous route.
5-10 mg/kg b.w. butafosfan + 0.0025-0.005 mg/kg b.w. cyanocobalamin (corresponding to 5-10 ml/100 kg b.w.).
For the supportive treatment of secondary ketosis: the recommended dose should be administered on three consecutive days.
For the prevention of ketosis: the recommended dose should be administered on three consecutive days within the period of 10 days before expected calving.
For other indications, treatment should be repeated as necessary.

Meat and offal: 0 days.
Milk: 0 hours.

Horses

Supportive treatment and prevention of hypophosphatemia and/or cyanocobalamin (vitamin B12) deficiency.

Adjunctive therapy in horses suffering from muscular exhaustion. 

Intravenous route.
5-10 mg/kg b.w. butafosfan + 0.0025-0.005 mg/kg b.w. cyanocobalamin (corresponding to 5-10 ml/100 kg b.w.).
Treatment should be repeated as necessary.

Meat and offal: 0 days.

Dogs

Supportive treatment and prevention of hypophosphatemia and/or cyanocobalamin (vitamin B12) deficiency.

Intravenous, intramuscular and subcutaneous route.
10-15 mg/kg b.w. butafosfan + 0.005-0.0075 mg/kg b.w. cyanocobalamin (corresponding to 0.1-0.15 ml/kg b.w.).
Treatment should be repeated as necessary.

Not applicable. 

Vials of 100 ml